Android app Apple app link

Palvella Therapeutics, Inc. (PVLA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$130.5
Day's range
$138.89

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/16/2026 Raymond James Ryan Deschner $226.00 $122.16   85.01%
07/22/2026 H.C. Wainwright Andrew Fein $270.00 $143.94   87.58%
12/16/2025 Canaccord Genuity Whitney Ijem $204.00 $88.42   130.72%
12/16/2025 Raymond James Ryan Deschner $193.00 $91.51   110.91%
12/15/2025 BTIG Jeff Mukherjee $192.00 $88.42   117.15%
12/15/2025 UBS Catherine Novack $143.00 $88.42   61.73%
12/11/2025 H.C. Wainwright Andrew Fein $190.00 $96.55   96.79%
12/04/2025 Craig-Hallum Albert Lowe $175.00 $91.91   90.4%
11/24/2025 Stifel Nicolaus Samimy Annabel $145.00 $94.09   54.11%
10/02/2025 Truist Financial Danielle Brill $80.00 $61.69   29.68%
09/24/2025 Stifel Nicolaus Annabel Samimy $80.00 $59.87   33.62%
08/15/2025 H.C. Wainwright Andres Maldonado $75.00 $45.94   63.26%
05/16/2025 Canaccord Genuity Whitney Ijem $52.00 $22.05   135.83%
03/25/2025 Stifel Nicolaus Annabel Samimy $45.00 $27.27   65.02%
12/18/2024 Cantor Fitzgerald Josh Schimmer $30.00 $11.79   154.45%

Palvella Therapeutics Inc. FAQ's

Palvella Therapeutics Inc. has been rated by research analysts at Raymond James, H.C. Wainwright, Chardan Capital, Truist Financial, Canaccord Genuity, Stephens in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.